ArticleOncoimmunology
Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines.
Sunil S Raikar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
56 papers cite it
cites it